期刊文献+

2型糖尿病伴牙周炎患者血清RANKL和骨保护素水平的检测及意义 被引量:4

Changes of Serum RANKL and Osteoprotegerin Levels and Their Significance in Diabetes Mellitus with Periodontitis
原文传递
导出
摘要 目的:探讨慢性牙周炎伴2型糖尿病患者血清RANKL和骨保护素(OPG)浓度变化与牙槽骨破坏的关系。方法:检查和分析健康组、牙周炎组、2型糖尿病组以及2型糖尿病伴牙周炎组患者血清RANKL和OPG的浓度、空腹血糖水平及牙周检查指数。结果:与健康组相比,牙周炎组OPG显著降低,RANKL略增高,RANKL/OPG比值增高(P<0.05);糖尿病组OPG明显增高,RANKL几无变化,RANKL/OPG比值降低(P<0.05);糖尿病伴牙周炎组OPG明显增高,RANKL略增高,RANKL/OPG比值降低;与牙周炎组相比,糖尿病组和糖尿病伴牙周炎组OPG明显增高,RANKL/OPG比值降低(P<0.05);空腹血糖与临床附着丧失,OPG浓度呈正相关,与RANKL/OPG比值呈负相关(P<0.05)。结论:糖尿病和牙周炎引起RANKL/OPG比值呈现不同的变化,提示糖尿病与牙周炎骨破坏机制可能不同,糖尿病患者与牙周病患者OPG浓度变化提示糖尿病患者的骨吸收可能还有未知的破骨机制。 Objective: To measure the serum levels of RANKL and osteoprotegerin(OPG) in patients of diabetes mellitus with or without periodontitis,and to explore the relationship between alveolar bone destruction and RANKL/OPG concentration.Methods: The levels of serum RANKL and OPG were compared among health(H),periodontitis(P),diabetes mellitus(DM) and DM+P groups including blood test and periodontal examination.Results: In periodontitis group,OPG was significantly lower,RANKL was slightly increased,RANKL/OPG ratio was higher(P0.05);in diabetes group,OPG was significantly higher(P0.05),RANKL had almost no change,and RANKL/OPG ratio was decreased(P0.05);in diabetes with periodontitis group,both RANKL and OPG were increased(P0.05),but the ratio was reduced(P0.05).In diabetes group and diabetes with periodontitis group,OPG was significantly higher(P0.05),RANKL/OPG ratio was decreased compared to periodontitis group(P0.05);fasting blood glucose was positively correlated to attachment loss and OPG levels(P0.05),and negatively correlated to RANKL/OPG ratio.Conclusion: The cause of diabetes and periodontitis in the change of RANKL/OPG ratio was different;the changes of RANKL and OPG concentrations in diabetes and periodontal patients suggest unknown bone resorption mechanism.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2012年第6期770-774,共5页 Medical Journal of Wuhan University
基金 "十一五"国家科技支撑项目(编号:2007BAI18B02)
关键词 糖尿病 牙周炎 RANKL 骨保护素 Diabetes Mellitus Periodontitis RANKL Osteoprotegerin
作者简介 曹玉林,女,1984-,医学硕士,主要从事牙周病治疗的研究 通信作者:李成章,男,1956~,医学博士,教授,主任医师,博士生导师,主要从事牙周病的宿主因素与引导牙周组织再生研究
  • 相关文献

参考文献16

  • 1Lu HK, Yang PC. Cross-sectional analysis of differentvariables of patients with non-insulin dependent diabe-tes and their periodontal status[J], Int J priodontiticsRes Dent,2004,24(1) :71-79.
  • 2Rodrigues DC* Taba MJ, Novaes AB, et al. Effect ofnon-surgical periodontal therapy on glycemic control inpatients with type 2 diabetes mellitus[J]. J Periodontal,2003,74(9) :1 361-1 367.
  • 3张晶,向晓明,李成章.RANKL/RANK/OPG调节系统在牙周炎发病机制中的作用[J].口腔医学研究,2005,21(4):472-474. 被引量:5
  • 4Sundeep K. Minireview: The OPG/RANKL/RANKSystem [J]. Endocrinology, 2001, 142 ( 12 ): 5 050-5055.
  • 5Bostanci N,Ilgenli T, Emingil G,et al. Gingival crevic-ular fuid levels of RANKL and OPG in periodontal dis-eases: implications of their relative ratio[J]. J Clin Pe-riodontology, 2007,34(5) :370-376.
  • 6Armitage GC,Wu Y, Wang HY, et al. Low prevalenceof a periodontitis-associated interleukin-1 compositegenotype in individuals of Chinese heritage[J]. J Peri-odontol,2000,71(2) .164-171.
  • 7Ritchie CS. Mechanistic links between type 2 diabetesand periodontitis [J]. J Dentistry, 2009, 37 (8): 578-579.
  • 8Loe H. Periodontal disease. The sixth complication ofdiabetes mellitus[J]. Diabetes Care,1993,16 (1) : 329-334.
  • 9Mogi M, Otogoto J. Ota N, et al. Differential expres-sion of RANKL and osteoprotegerin in gingival cervicu-lar fluid of patients with periodontitis[J]. J Dental Re-search, 2004,83(2) : 166-169.
  • 10Valverde P, Kawai T . Taubman MA,et al. Selectiveblockade of voltage-gated potassium channels reducesinflammatory bone resorption in experimental periodon-tal disease[J]. J Bone Miner Res, 2004,19(1): 155-164.

二级参考文献20

  • 1Lacey DL, Timms E, Tan HL,et al. Osteoprotegerin Ligand is a cytokine that regulates osteoclast differentiation and activation [J]. Cell, 1998, 93(2):165-176
  • 2Anderson DM, Maraskovsky E, Billingsley WL, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J]. Nature, 1997, 390(6656):175-179
  • 3Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density [J]. Cell, 1997, 89(2):309-319
  • 4Burgess TL, Qian YX, Kaufman S, et al. The ligand for osteoprotegerin (OPGL)directly activates mature osteoclasts [J]. J Cell Biol, 1999, 145(3):527-538
  • 5Yong YK,Yoshida H, Sarosui I, et al. OPGL is a key regulator of osteoclastogenesis,lymphocyte development and lymph-node organogenesis [J]. Nature, 1999, 397(6717):315-323
  • 6Dougall WC, Glaccum M, Charrier K, et al. RANK is essential for osteoclast and lymphonode development [J]. Genes Dev, 1999, 13(18):2 412-2 424
  • 7Kobayashi-Sakamoto M, Hirose K, Isogai E, et al. NF-jB-dependent induction of osteoprotegerin by Porphyromonas gingivalis in endothelial cells [J]. Biochem Biophys Res Commun, 2004, 315(1):107-112
  • 8Bucay N, Sarosi I, Dunstan CR, et al. OPG-deficient mice develop early onset osteoporosis and arterial calcification [J]. Genes Dev, 1998, 12(9):1 260-1 268
  • 9Liu D, Xu JK, Figliomeni L, et al. Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction [J]. Int J Mol Med,2003,11:17-21
  • 10Crotti T, Smith MD, Hirsch R, et al. Receptor activator NF-κB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis [J]. J Periodont Res, 2003, 38:380-387

共引文献4

同被引文献31

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部